bioRxivCell Biology
ROS/RNS balancing, aerobic fermentation regulation and cell cycle control a complex early trait ('CoV-MAC-TED') for combating SARS-CoV-2-induced cell reprogramming
J. H. Costa, G. Mohanapriya, B. Revuru, C. Noceda, K. L. L. Thiers, S. Aziz, S. Srivatsava, M. Oliveira, K. J. Gupta, A. Kumari, D. Sircar, S. R. Kumar, A. Achra, R. Sathishkumar, A. Adhloeya, B. Arnholdt-Schmitt
Abstract
In a perspective entitled From plant survival under severe stress to anti-viral human defense we raised and justified the hypothesis that transcript level profiles of justified target genes established from in vitro somatic embryogenesis (SE) induction in plants as a reference compared to virus-induced profiles can identify differential virus signatures that link to harmful reprogramming. A standard profile of selected genes named ReprogVirus was proposed for in vitro-scanning of early virus-induced reprogramming in critical primary infected cells/tissues as target trait. For data collection, the ReprogVirus platform was initiated. This initiative aims to identify in a common effort across scientific boundaries critical virus footprints from diverse virus origins and variants as a basis for anti-viral strategy design. This approach is open for validation and extension. In the present study, we initiated validation by experimental transcriptome data available in public domain combined with advancing plant wet lab research. We compared plant-adapted transcriptomes according to RegroVirus complemented by alternative oxidase (AOX) genes during de novo programming under SE-inducing conditions with in vitro corona virus-induced transcriptome profiles. This approach enabled identifying a major complex trait for early de novo programming during SARS-CoV-2 infection, called CoV-MAC-TED. It consists of unbalanced ROS/RNS levels, which are connected to increased aerobic fermentation that links to alpha-tubulin-based cell restructuration and progression of cell cycle. We conclude that anti-viral/anti-SARS-CoV-2 strategies need to rigorously target CoV-MAC-TED in primary infected nose and mouth cells through prophylactic and very early therapeutic strategies. We also discuss potential strategies in the view of the beneficial role of AOX for resilient behavior in plants. Furthermore, following the general observation that ROS/RNS equilibration/redox homeostasis is of utmost importance at the very beginning of viral infection, we highlight that de-stressing disease and social handling should be seen as essential part of anti-viral/anti-SARS-CoV-2 strategies.
- organism: plant (other)
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Major complex trait for early de novo programming 'CoV-MAC-TED' detected in human nasal epithelial cells infected by two SARS-CoV-2 variants is promising for designing therapeutic strategies
J. H. Costa, S. Aziz, … C. Noceda·bioRxiv·Oct 19, 2021
- Transcriptome data from human nasal epithelial cells infected by H3N2 influenza virus indicate early unbalanced ROS/RNA levels, temporarily increased aerobic fermentation linked to enhanced α-tubulin and rapid energy-dependent IRF9-marked immunization
J. H. Costa, S. Aziz, … C. Noceda·bioRxiv·Oct 18, 2021
- Differential roles of RIG-I-like receptors in SARS-CoV-2 infection
- SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export
R. Hall, A. Guedan, … K. N. Bishop·bioRxiv·Feb 8, 2022
- Network-based identification and pharmacological targeting of host cell master regulators induced by SARS-CoV-2 infection
P. Laise, M. L. Stanifer, … M. J. Alvarez·bioRxiv·Jul 3, 2021
- Dynamics of SARS-CoV-2 host cell interactions inferred from transcriptome analyses
Lukas Adam, Megan Lynn Stanifer, … Stefan M. Kallenberger·Science SignalingPeer-reviewed·Sep 26, 2023